Tasimelteon Capsule, Gelatin Coated
Product Images NDC 0480-4490

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tasimelteon (NDC 0480-4490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of the active ingredient Tasimelteon, showing its molecular framework including a fused bicyclic ring, a cyclopropane group, and an amide functional group.*

FDA Label Image

Label 20 mg, 30 Capsules (Image 2)

Label for Tasimelteon Capsules 20 mg gelatin-coated capsules. Contains 30 capsules per package. Manufactured by Watson Pharma Private Limited in India for Teva Pharmaceuticals, Inc. Includes dosage instructions and storage conditions, plus a barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.